Gastro Retentive Drug Delivery Systems Market
Gastro-retentive Drug Delivery Systems Market Forecasts to 2030 - Global Analysis By Type (Expandable Drug Delivery System, Bioadhesive Drug Delivery System, Floating Drug Delivery System (FDDS), High Density System and Other Types), Dosage Form (Microspheres, Tablets, Capsule and Other Dosage Forms), Distribution Channel and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $14.9 BN |
|
Projected Year Value (2030) |
US $33.1 BN |
|
CAGR (2023 - 2030) |
12.1% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Gastro-retentive Drug Delivery Systems Market is accounted for $14.9 billion in 2023 and is expected to reach $33.1 billion by 2030 growing at a CAGR of 12.1% during the forecast period. The term "gastro-retentive drug delivery" refers to methods, formulations, production techniques, storage systems, and technologies used to deliver pharmaceutical compounds to the target location in the gastro-intestinal tract, to enhance the effectiveness and safety of a drug delivery system, principles relating to drug manufacturing, route of administration, site-specific targeting, metabolism, and toxicity are applied. The enhancement of mucosal protection by the gastro-retentive drug delivery method can be used to prevent and control the condition.
According to the article published by the University of Arizona, H.pylori infection is higher in developing countries than the developed countries. The incidence of new infections in developing countries is 3 to 10% of the population compared to 0.5% in developed economies.
Market Dynamics:
Driver:
Rising demand for gastro-retentive drugs
The market's growth has been accelerated by large pharmaceutical companies' efforts to improve gastro-retentive drug delivery systems, together with dose reductions due to improved bioavailability and an increase in the demand for drugs. Additionally, the market is greatly influenced by the well-established effectiveness of gastro-retentive drug delivery systems in treating various kinds of stomach disorders, including peptic ulcer and gastric ulcer, as well as an increase in the prevalence of H.pylori infection, which can lead to gastritis and gastric cancer which enabled the use of gastro-retentive drugs resulting in market expansion.
Restraint:
Decrease in Patient acceptance
The innovative nature of these new medicine delivery techniques may make them difficult for patients to accept. Additionally, patients may prefer traditional oral dosage forms especially for individuals who have difficulty swallowing or who prefer smaller-sized dosage forms. Moreover, ensuring consistent compliance is also challenging, as it relies on patients following specific administration instructions. Thus, some patients may find the size or characteristics of Gastro-retentive Drug Delivery Systems (GRDDS) less convenient by which the market gets significantly retrain.
Opportunity:
Technological advancements
The use of gastro-retentive drug delivery technology has proven to be an effective technique to control the dosage of a variety of pharmaceuticals while increasing bioavailability. Moreover, technology innovations that go beyond physical challenges like erratic stomach emptying timings and brief gastric residency times have led to improvements in controlled oral medicine administration systems in recent years. Additionally, once-GRDDS can improve therapeutic effectiveness and oral bioavailability by prolonging their duration in the upper GI tract. Hence, these advancements drive the market size.
Threat:
Risks associated while formulating
There are challenging obstacles to overcome when creating pharmacological formulations that can consistently stick to the gastrointestinal mucosa or float in the stomach while releasing the drug at a controlled rate. Moreover, it takes exact formulation methods and in-depth research to achieve this balance of adhesion, buoyancy, and controlled release. Additionally, the difficulty is increased further by the need to ensure the drug's stability in the gastrointestinal environment. Therefore, these difficulties frequently lead to longer development times and higher prices, which have an effect on market growth.
Covid-19 Impact
The market for gastro-retentive drug delivery systems (GRDDS) has been negatively impacted by the COVID-19 epidemic. Clinical trials and research for the development of GRDDS-based drugs were delayed while healthcare systems concentrated on fighting the virus. Additionally, access to medical facilities became restricted, which had an impact on the recruitment of patients for clinical trials and the uptake of innovative drug delivery methods. Moreover, economical limitations and supply chain interruptions have hampered the manufacture and distribution of GRDDS goods. Therefore, budgets for novel drug delivery methods were impacted as a result of the pandemic's increasing financial load on healthcare systems which gradually hampered the market growth.
The floating drug delivery system (FDDS) segment is expected to be the largest during the forecast period
The floating drug delivery system segment is estimated to hold the largest share. These are drug formulations that remain buoyant in the stomach for an extended period. Additionally, these methods allow medications to release gradually while floating on the gastric fluid, improving drug absorption and extending therapeutic benefits. Floating drug delivery system (FDDS) can reduce side effects, decrease dosage frequency, and increase drug absorption. Furthermore, they are particularly helpful for medications with small absorption windows and are used in the treatment of a variety of gastrointestinal ailments. Therefore, a cutting-edge method for improving medication delivery, FDDS ensures higher patient compliance and therapeutic effectiveness in gastro-retentive medicines thereby increasing the market expansion.
The microspheres segment is expected to have the highest CAGR during the forecast period
The microspheres segment is anticipated to have highest CAGR during the forecast period due to the use of small, spherical particles in medicine formulations to improve absorption of the medicament in the gastrointestinal tract. Additionally, these microspheres can contain medications for controlled release and are typically made of biocompatible substances. They provide advantages after consumption, including longer drug administration, decreased dosage frequency, and reduced side effects. GRDDS with microspheres is used to treat a variety of gastrointestinal illnesses, enhancing patient compliance and therapeutic results. Hence, this section shows an original pharmacological strategy for enhancing gastrointestinal system drug absorption and therapeutic efficacy by significantly driving the market.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period owing to due to their better drug absorption and patient compliance. Additionally, the Asia-Pacific region is spending money on medical research and infrastructure, which encourages innovation and market growth. Adoption of GRDDS is further fuelled by regulatory changes and the rise in chronic diseases. Therefore, pharmacies, researchers, and healthcare practitioners in the GRDDS industry have a lot of opportunities in this region.
Region with highest CAGR:
Europe is expected to witness highest CAGR over the projection period, owing to a major role in the advancement of GRDDS technology, placing a strong emphasis on both innovation and high-quality healthcare. Additionally, there is a need for better drug delivery methods due to the aging population in the area and the high prevalence of gastrointestinal illnesses. Moreover, in order to improve treatment outcomes, patient compliance, and quality of life, European healthcare systems encourage the development and deployment of GRDDS. Hence, stringent regulatory standards ensure product safety, making it a thriving market.
Key players in the market
Some of the key players in the Gastro-retentive Drug Delivery Systems Market include Ranbaxy, GlaxoSmithKline, Competition Deep Dive, Depomed, Pharmacia, Alcon, Inc., Lupin, Galanix, Sun Pharma and F. Hoffmann La Roche.
Key Developments:
In October 2023, Sun Pharmaceutical Industries Ltd announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for deuruxolitinib, an investigational oral selective inhibitor of Janus kinases, for the treatment of adults with moderate to severe alopecia areata.
In March 2023, Sun Pharmaceutical Industries Limited announced the successful completion of its acquisition of Concert Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company that is developing deuruxolitinib, a novel, deuterated, oral JAK1/2 inhibitor, for the potential treatment of adult patients with moderate to severe alopecia area.
Types Covered:
• Expandable Drug Delivery System
• Bioadhesive Drug Delivery System
• Floating Drug Delivery System
• High Density System
• Other Types
Dosage Forms Covered:
• Microspheres
• Tablets
• Capsule
• Other Dosage Forms
Distribution Channels Covered:
• Online Pharmacies
• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channels
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Gastro-retentive Drug Delivery Systems Market, By Type
5.1 Introduction
5.2 Expandable Drug Delivery System
5.3 Bioadhesive Drug Delivery System
5.4 Floating Drug Delivery System (FDDS)
5.5 High Density System
5.6 Other Types
6 Global Gastro-retentive Drug Delivery Systems Market, By Dosage Form
6.1 Introduction
6.2 Microspheres
6.3 Tablets
6.4 Capsule
6.5 Other Dosage Forms
7 Global Gastro-retentive Drug Delivery Systems Market, By Distribution Channel
7.1 Introduction
7.2 Online Pharmacies
7.3 Hospital Pharmacies
7.4 Retail Pharmacies
7.5 Other Distribution Channels
8 Global Gastro-retentive Drug Delivery Systems Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Ranbaxy
10.2 GlaxoSmithKline
10.3 Competition Deep Dive
10.4 Depomed
10.5 Pharmacia
10.6 Alcon, Inc.
10.7 Lupin
10.8 Galanix
10.9 Sun Pharma
10.10 F. Hoffmann La Roche
List of Tables
1 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Region (2021-2030) ($MN)
2 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
3 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
4 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
5 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
6 Global Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
7 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
8 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
9 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
10 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
11 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
12 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
13 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
14 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
15 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
16 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
17 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
18 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
19 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
20 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
21 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
22 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
23 North America Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
24 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
25 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
26 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
27 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
28 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
29 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
30 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
31 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
32 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
33 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
34 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
35 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
36 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
37 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
38 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
39 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
40 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
41 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
42 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
43 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
44 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
45 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
46 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
47 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
48 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
49 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
50 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
51 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
52 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
53 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
54 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
55 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
56 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
57 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
58 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
59 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
60 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
61 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
62 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
63 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
64 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
65 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
66 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
67 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
68 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
69 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
70 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
71 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
72 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
73 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
74 South America Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
75 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
76 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
77 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
78 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
79 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
80 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
81 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
82 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
83 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
84 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
85 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
86 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
87 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
88 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
89 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
90 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
91 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
92 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
93 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
94 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
95 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
96 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
97 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
98 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
99 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
100 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
101 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
102 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
List of Figures
List of Figures
Figure 1 Global Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 2 North America Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 3 US Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 4 Canada Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 5 Mexico Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 6 Europe Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 7 Germany Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 8 UK Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 9 Italy Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 10 France Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 11 Spain Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 14 Japan Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 15 China Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 16 India Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 17 Australia Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 19 South Korea Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 21 South America Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 22 Argentina Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 23 Brazil Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 24 Chile Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 28 UAE Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 29 Qatar Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 30 South Africa Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook (2021-2030) ($MN)
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
